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Background: Lymph node metastasis is one of the most critical prognostic factors in 
patients with colorectal cancer. Although regional lymph nodes should be surgically 
resected and pathologically examined, techniques for the intraoperative diagnosis of 
lymph node metastasis remain to be well established. Fluorescence diagnosis using 
5-aminolevulinic acid (5-ALA) is a promising technique for evaluating various 
malignancies. After exogenous administration of 5-ALA, protoporphyrin IX (PPIX) 
accumulates in malignant cells and can be detected as red fluorescence. In this study, we 
investigated the usefulness of fluorescence diagnosis using 5-ALA for the detection of 
lymph node metastasis in a mouse model of colon cancer. 
Materials and Methods: An orthotopic colon cancer model was prepared by inoculating 
the cecal wall of nude mice with HCA7, a human colon adenocarcinoma cell line. After 
3 weeks, 40 mg/kg of 5-ALA was administered intraperitoneally (IP) or orally (PO). 
Fluorescence diagnosis with a D-Light System (Karl Storz) was then performed after 3 
or 6 hours.  
Results: In the IP group, PPIX fluorescence was detected in metastatic lymph nodes as 
well as in other malignant lesions, including primary tumors and abdominal 
implantations, while non-metastatic nodes were fluorescence-negative. In contrast, no 
obvious fluorescence was detected in cancerous tissues in the PO group. 
Conclusions: PPIX fluorescence induced by intraperitoneal injection of 5-ALA allows 
metastatic lymph nodes to be accurately diagnosed in this mouse model. This technique 
may facilitate the intraoperative diagnosis of lymph node metastases from colon cancer 
in a clinical setting. 
 






Colorectal cancer is a very common type of cancer worldwide and is now the third 
leading cause of cancer-related death in Japan [1, 2]. The presence of lymph node 
metastasis is clearly related to the prognoses of patients, and accurate diagnosis of nodal 
involvement is essential to planning therapeutic strategies, such as an extent of lymph 
node dissection and adjuvant chemotherapy [3-6]. The goal of surgical treatment for 
colon cancer is the resection of the involved bowel segment and its lymphatic drainage 
at the level of the primary feeding arterial vessel (e.g., ileocolic, middle colic, left colic, 
inferior mesenteric artery) [6, 7]. Postoperative pathological examination is currently 
the gold standard for evaluating regional lymph node metastasis.  
 Despite improvements in preoperative imaging, such as computed tomography 
(CT), magnetic resonance tomography (MRI), and fluorodeoxyglucose positron 
emission tomography (FDG-PET), it is still difficult to accurately assess nodal 
involvement. Techniques for intraoperative diagnosis of lymph node metastases, 
including sentinel lymph node biopsy, also remain to be well established [3]. If lymph 
node metastases were able to be accurately diagnosed at the time of surgical retrieval, 
the extent of lymph node dissection could be determined in accordance with the nodal 
status of each patient. Most surgeons believe that appropriate lymphadenectomy can 
improve short- and long-term outcomes, although evidence supporting the therapeutic 
significance of lymph node dissection is rather limited [6, 8]. 
 Fluorescence diagnosis using 5-aminolevulinic acid (5-ALA) is a promising 
technique that has been used to evaluate various kinds of malignancies in neurosurgery 
[9, 10], urology [11, 12], dermatology [13, 14], thoracic surgery [15], gynecology [16], 
and gastrointestinal surgery [17]. After exogenous administration of 5-ALA, 
protoporphyrin IX (PPIX), the last metabolite in heme synthesis, accumulates in 
malignant cells. Although the mechanism of PPIX accumulation has not been 
completely defined, several factors concerning 5ALA metabolism, such as reduced 
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activity of ferrochelatase, which converts PPIX to heme, low Fe
2+
 levels, and increased 
NO, are possibly involved rather than 5ALA uptake [18-20]. PPIX can be detected as 
red fluorescence when excited by blue light with a wavelength of 405 nm, enabling 
tumor lesions to be distinguished from normal tissues.  
 In this study, we evaluated the effectiveness of fluorescence diagnosis, using 
5-ALA administered intraperitoneally or orally, for the detection of lymph node 
metastases from colon cancer in an experimental setting. 
 
 
Materials and methods 
Animals 
5- to 8-week-old female KSN nu/nu mice were purchased from Japan SLC (Hamamatsu, 
Japan). The mice had been raised from birth in a specific pathogen-free environment, 
and all in vivo experiments were conducted in accordance with the institutional 
guidelines of Kyoto University Hospital. 
 
Cell line 
Wild-type and green fluorescent protein (GFP)-labeled human colon adenocarcinoma 
cell line, HCA7, was cultured in D-MEM (Wako Pure Chemical Industries, Osaka, 
Japan) with 10% serum and penicillin/streptomycin and maintained at 37˚C in a 
humidified incubator with 5% CO2 in air. HCA7 cell line stably expressing GFP was 
generated by retroviral transfection with GFP, as described previously [21]. 
 
Tumor model 
An orthotopic colon cancer model was prepared by inoculating the cecal wall of the 
mice with cancer cells. The animals were anesthetized with diethyl ether and then 





tumor cells in 30 µl of sterile PBS were injected into the subserosal layer of the cecal 
wall with a 30-gauge needle. The abdominal wall was closed with a 5-0 surgical suture 
in one layer. After tumor inoculation, the animals were kept under standard laboratory 
conditions: food and water were available ad libitum, and illumination was provided 
according to a 12-hour light/dark cycle.  
 
5-ALA administration 
5-ALA (5-aminolevulinic acid hydrochloride, Cosmo Bio, Tokyo, Japan) was diluted to 
10 mg/ml with distilled water just before use. Three weeks after surgery, 40 mg/kg of 
5-ALA was administered intraperitoneally (IP group) or orally (PO group). The animals 
were kept in a dark room until observation. 
 
Observation  
3 or 6 hours after 5-ALA administration, the animals were anesthetized and underwent 
laparotomy using the prior incision in a darkroom. Fluorescence diagnosis was 
performed with a 4-mm endoscope (Hopkins II, 30°, Karl Storz GmbH, Tuttlingen, 
Germany) connected to a CCD camera (TRICAM PDD, Karl Storz) and a D-Light 
System (Karl Storz). This instrument allows three different modes: conventional white 
light mode, auto-fluorescence mode, and photodynamic diagnosis (PDD) mode for 
PPIX fluorescence. These modes can be easily switched through the use of a footswitch 
or a button on the camera head. In PDD mode, a specific blue light (380-440 nm) is 
emitted, and the observation filter in the endoscope eyepiece blocks most of the 
excitation light. A defined amount of blue light passing through the filter allows color 
contrast and orientation in fluorescence-negative areas. Thus, this mode is highly 
specialized for the detection of PPIX fluorescence.  
 After exploring the abdominal cavity with the D-Light System in both white 
light and PDD modes, we extirpated the intestine along with the mesentery and 
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examined the mesenteric lymph nodes again in both modes.  
 
Histopathology 
After observation, lymph nodes and some other tissues were extracted and soaked in 4% 




Formation of lymph node metastasis 
We treated 23 animals in all, and details of experiments were described in Table 1. 
Three weeks after cancer-cell inoculation, tumors were successfully generated at the 
injection site in all experiments (Fig. 1a). We identified metastases in some 
meso-colonic lymph nodes (Fig. 1b). Large numbers of small nodules spreading along 
the mesenteric vessels were found in all 23 mice (Fig. 1a). These nodules were 
ascertained to be metastases from cecal tumors on both histopathological examination 
and GFP fluorescence (Fig. 1c). In addition, abdominal wall implantations and 
peritoneal metastases had developed, accompanied by the accumulation of more or less 
bloody ascitic fluid (Fig. 1a).  
 
IP group (5-ALA injected intraperitoneally) 
Typical PPIX red fluorescence was observed in the skin, gallbladder, and small and 
large intestines after intraperitoneal injection of 5-ALA (data not shown). In 3 of 10 
animals, meso-colonic lymph nodes showed red fluorescence focally and were 
pathologically confirmed to be metastatic (Fig. 2a, 2b, Table 1). In contrast, 
non-metastatic lymph nodes were fluorescence-negative (Fig. 2a, 2b). All nodules in the 
mesentery that were visible under white light showed clear red fluorescence (Fig. 3a, 
Table 1). Primary tumors and abdominal wall implantations also showed red 
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fluorescence (Fig. 3b, 3c). Moreover, PPIX fluorescence was detected in peritoneal 
tissues around the stomach, which proved to be metastases to the pancreas (Fig. 3d). 
The intensity of the fluorescence at 3 hours was considerably stronger than that at 6 
hours.  
 
PO group (5-ALA given orally) 
Red fluorescence in the skin, gallbladder, and small and large intestines was observed 
after oral administration of 5-ALA, similar to that in the IP group (data not shown). 
PPIX fluorescence was not detected in any meso-colonic lymph nodes or mesenteric 
nodules at either interval (Fig. 4, Table 1). Only faint fluorescence was seen in some 
parts of primary tumors and abdominal wall implantations (data not shown). 
 
Discussion 
Fluorescence diagnosis using 5-ALA has been studied in various fields since Marik et al. 
first reported the value of this photosensitizer in 1987 [22]. Neurosurgeons in Europe 
have already used this technique clinically for the intraoperative detection of malignant 
gliomas [10, 23]. The European Association of Urology guidelines also recommend 
photodynamic diagnosis using hexaminolevulinate (HAL), a hexyl ester derivative of 
5-ALA, for the detection of bladder carcinomas [24]. Although the mechanisms of PPIX 
accumulation remain to be fully defined, this phenomenon is thought to be very 
tumor-specific. To date, few studies have focused on the ability of 5-ALA to detect 
lymph node metastases from cancers [25-29]. Thus, we evaluated the usefulness of 
fluorescence diagnosis using 5-ALA for the detection of lymph node metastases from 
colon cancers. Our results demonstrated that PPIX fluorescence induced by 
intraperitoneal administration of 5-ALA, not by oral, allowed metastatic lymph nodes to 
be accurately diagnosed in this mouse model. 
 Before conducting in vivo experiments, 5-ALA-mediated PPIX accumulation 
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in HCA7 was confirmed by fluorescence microscopy, using an in vitro method similar 
to that employed in previous studies (data not shown) [25, 30]. To induce regional 
lymph node metastases, we orthotopically injected a suspension of the HCA7 cell line. 
The metastasis rate of this model was estimated at approximately 25% by earlier 
experiments. In addition, a substantial number of nodules in the mesentery were formed 
in all 23 mice within 3 weeks. Histopathological examination confirmed that most of 
these nodules contained cancer cells and were thus considered metastases from the cecal 
tumor. Because the nodules were distributed along the mesenteric vessels and appeared 
to be located between the peritoneum, they were most likely metastatic lymph nodes 
rather than peritoneal dissemination.  
 Our results in the IP group showed that 5-ALA-induced PPIX fluorescence was 
successfully detected in metastatic portions of regional lymph nodes, while no apparent 
fluorescence was observed in non-metastatic nodes. Actually, the distribution of 
fluorescence was associated with pathological findings. We detected PPIX fluorescence 
in meso-colonic nodes in 3 of 10 animals, and these fluorescent nodes were 
pathologically confirmed to be metastatic. This ratio would be compatible with the 
metastatic rate of this model. Unfortunately, we had performed pathological 
examination not for all lymph nodes, so we cannot exactly describe the sensitivity or 
specificity of this technique. However, mesenteric nodules, which were formed in all 
animals and detected macroscopically, showed clear red fluorescence. The fluorescence 
was bright enough to detect tiny tumors, which were hardly visible under white light. 
These results suggest the strong ability of intraperitoneal 5ALA to detect cancer tissues. 
In addition, primary tumors, abdominal implantations, and pancreatic metastases also 
showed red fluorescence, suggesting that intraperitoneal 5-ALA might be applied for 
the intraoperative detection not only of lymph node metastases but also of other occult 
peritoneal metastases. 
 Fluorescence at 3 hours was much stronger than that at 6 hours in the IP group. 
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A previous study using colon carcinoma cell lines for a peritoneal carcinosis model 
reported that PPIX accumulation and fluorescence peaked 2 to 4 hours after 
intraperitoneal lavage with 5-ALA [31]. For bladder carcinomas, it is also recommended 
that 5-ALA is administered intravesically 2-3 hours before cytoscopy. On the other hand, 
Sroka et al. demonstrated that the maximum contrast of fluorescence intensity between 
tumors and non-malignant organs was observed 4 to 6 hours after intravenous injection 
of 5-ALA in a subcutaneous tumor model with colon adenocarcinoma cells [32]. The 
time to the peak fluorescence may differ depending on the route of administration. Our 
results suggest that 2 to 4 hours after intraperitoneal 5-ALA administration is the 
optimal time for detecting lymph node metastases from colon cancers. 
 Our results indicated that PPIX fluorescence could not be detected in metastatic 
lymph nodes at 3 or 6 hours after oral administration of 40 mg/kg of 5-ALA. We used 
the same dose as that in the IP group, and the fluorescence intensity of the skin, 
gallbladder, and intestines appeared to be similar in both groups, suggesting no 
appreciable difference in systemic distribution of 5-ALA. The PPIX concentration does 
not significantly differ between oral and intravenous administration, because oral 
5-ALA is well absorbed in the upper part of the intestines [23, 35, 36]. Gahlen et al. 
compared systemic with local administration of 5-ALA for the fluorescence diagnosis of 
intraperitoneal tumors [33]. They found that local administration was superior; 
nevertheless, the total dose of 5-ALA was 4- to 5- fold higher than that used for 
intravenous injection. One hypothesis proposes that intraperitoneally administered 
5-ALA is absorbed through the peritoneum and distributed via both the systemic 
circulation and by direct uptake into peritoneal tissues, resulting in higher 5-ALA 
concentrations and greater PPIX accumulation in lymph nodes and other intraperitoneal 
organs as compared with systemic administration [31, 33, 34].  
 A recent study demonstrated that intravenous injection of 5-ALA was 
extremely sensitive for the detection of lymph node metastases from rectal cancers, 
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even though the dose was as high as 250 mg/kg body weight [25]. A study in breast 
cancer reported that it was rather difficult to detect the fluorescence intraoperatively in 
metastatic sentinel lymph nodes after oral administration of 30 mg/kg of 5-ALA, 
although the fluorescence intensity of metastatic lymph nodes was significantly higher 
than that of non-metastatic lymph nodes [27]. Another study showed that the porphyrin 
concentrations of cancerous tissues rose dose-dependently after an intravenous dose of 
up to 300 mg/kg of 5-ALA [37]. These findings suggest that PPIX fluorescence would 
probably be detected after oral administration of a much higher dose of 5-ALA than that 
in our model. Many experimental studies have indicated that 5-ALA can be 
administered in much higher doses without serious side effects [23, 38]. Nonetheless, 
most clinical studies have used relatively low doses of up to 60 mg/kg body weight [17, 
26-28, 34, 39], and the only approved dose of oral 5-ALA is as little as 20 mg/kg for the 
detection of gliomas [23, 38]. Increasing the oral dose of 5-ALA thus appears to be 
impractical for the fluorescence diagnosis of lymph node metastases.  
 In this small study, we had not fully evaluated the sensitivity and specificity of 
5-ALA-induced fluorescence diagnosis of lymph node metastasis. Further precise 
studies with this animal model which verify the sensitivity and specificity are required 
to promote clinical translation of this technique. 
 The penetration depth of red light (630 nm) ranges from 0.2 to 2 cm, and that 
of exciting blue light (380-440 nm) is even shallower [31]. Moreover, the penetration 
depth of intraperitoneally administered 5-ALA within lymph nodes is unknown. As 
discussed previously, these factors might affect the detecting ability in deeper tissue 
layers [25, 31]. However, the marginal sinus is generally regarded as the initial site of 
cancer-cell proliferation in regional lymph nodes [40]. Furthermore, PPIX fluorescence 
induced by intraperitoneal 5-ALA was strong enough to detect, easily and effectively, 
small metastases within 1-2 mm in diameter in our mouse model. Diagnostic capability 
for human cancers associated with large lymph nodes, thick layers of endoceliac fat, or 
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both should be evaluated in future. 
 There is another limitation in translating our technique to clinical use. 
Intraperitoneal administration of 5-ALA should be performed under general anesthesia, 
but it may not be practical to wait for more than 2 hours in the operating room while 
avoiding exposure to light. Derivatives of 5-ALA, such as HAL, which have better 
bioavailability than the parent molecule, might solve this problem by shortening the 
incubation time [41]. Such derivatives are also expected to more potently induce 
fluorescence in cancers after intraperitoneal administration [42].   
 In conclusion, our results demonstrate that fluorescence diagnosis using 
intraperitoneally administered 5-ALA efficiently detects lymph node metastases from 
colon cancer in mice. With further investigations, this technique would serve the 
intraoperative diagnosis of lymph node metastases in patients with colon cancer, and 
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Figure 1. Formation of lymph node metastasis 3 weeks after orthotopic inoculation of 
HCA7.  
(a) Macroscopic imaging of the abdominal cavity. Metastases in meso-colonic lymph 
nodes (arrow heads) were identified in approximately 25% of the mice. The primary 
tumor (T) and abdominal wall implantations (*) were also developed. In addition, large 
numbers of nodules were formed in the mesentery (arrows). (b) White light image of a 
meso-colonic lymph node metastasis (arrow head). (c) Mesenteric nodules that were 
visible under white light showed GFP fluorescence under PDD mode (right panel) in the 
experiments using GFP-labeled cells.  
 
Figure 2. Fluorescence imaging of metastatic lymph nodes after intraperitoneal injection 
of 5-ALA (IP group).  
(a) PPIX fluorescence was detected in metastatic parts of meso-colonic lymph nodes 
(arrow). Non-metastatic lymph nodes were fluorescence-negative (arrow heads). (b) 
H&E sections of the lymph nodes shown in a; corresponding to the arrow (reight panel) 
and the arrow head (left panel).  (Magnifications: 40×) 
 
Figure 3. Fluorescence imaging of other cancerous lesions after intraperitoneal injection 
of 5-ALA (IP group).  
(a) All nodules in the mesentery that were visible under white light showed clear red 
fluorescence under PDD mode. Non-metastatic meso-colonic lymph nodes were 
fluorescence-negative (arrow heads). (b, c) The primary tumor and abdominal wall 
implantation showed red fluorescence. (d) PPIX fluorescence was also detected in 




Figure 4. Fluorescence imaging after oral administration of 5-ALA (PO group).  
PPIX fluorescence was not detected in any meso-colonic lymph nodes (arrow) or 
mesenteric nodules (arrow heads) at either interval. (left panel; white light mode, right 

















Table 1. Details of Experiments 
 
Route of administration IP PO 
Time after administration 3hrs 6hrs 3hrs 6hrs 
No. of animals 4 6 3 10 
PPIX fluorescence in 
meso-colonic nodes, No. 
    
  Positive 1 2 0 0 
  Negative 3 4 0 0 
PPIX fluorescence in 
mesenteric nodules, No. 
    
  Positive 4 6 0 0 
  Negative 0 0 3 10 
 
